Interferon Regulatory Factor 8 (IRF8) (C-Term) Peptide

Details for Product No. ABIN1382220
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Protein Name
Synonyms ICSBP, IRF-8, ICSBP1, H-ICSBP, Myls, Icsbp1, AI893568, icsbp1, zgc:92252, IRF8, MGC140338, DKFZp469B0320
Protein Region
(1), (2), (1), (1)
Blocking Peptide (BP)
Pubmed 3 references available
Catalog no. ABIN1382220
Quantity 0.05 mg
77.00 $   Plus shipping costs $45.00
Shipping to United States (Change)
Availability Will be delivered in 2 to 3 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Characteristics 16 amino acids near the carboxy terminus of human IRF8.
Alternative Name IRF8
Research Area Immunology, Innate Immunity, Transcription Factors
Application Notes IRF8 peptide is used for blocking the activity of IRF8.
Restrictions For Research Use only
Format Liquid
Concentration 200 µg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Storage -20 °C
Expiry Date 12 months
Background publications Weisz, Marx, Sharf et al.: "Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes." in: The Journal of biological chemistry, Vol. 267, Issue 35, pp. 25589-96, 1993 (PubMed).

González-García, Pérez-Ballestero, Ding et al.: "bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria." in: Development (Cambridge, England), Vol. 120, Issue 10, pp. 3033-42, 1995 (PubMed).

Heiser, Labi, Erlacher et al.: "The Bcl-2 protein family and its role in the development of neoplastic disease." in: Experimental gerontology, Vol. 39, Issue 8, pp. 1125-35, 2004 (PubMed).

Reactivities (1), (2), (1), (1)
back to top